# Whey Protein Muscle Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/whey-protein-muscle-randomized-trial-evidence-review
Category: evidence-review
Summary: Whey Protein Muscle Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sy
Last reviewed: 2026-06-15
Reviewed by: Migaku Evidence Review
# Whey Protein Muscle Randomized Trial: What the Evidence Says

## Quick Answer

Whey Protein Muscle Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta-Analysis and Meta-Regression of Randomized Controlled Trials | systematic review | 1 | 2026-04-29 | 10.3390/nu18091409 |
| Targeting muscle–vasculature crosstalk in aging through the integrative roles of L-citrulline, leucine, and exercise: focus on muscle metabolism, vascular function, and sarcopenia prevention | preclinical study | 4 | 2026-04-02 | 10.3389/fnut.2025.1739173 |

## What The Sources Report

- Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly. [Lin Che-Li (2026); evidence level 1]
- The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults. [Lin Che-Li (2026); evidence level 1]
- Within this framework, integrative approaches that combine nutritional and exercise interventions have garnered significant scholarly attention as pivotal strategies to mitigate age-associated declines in both muscular and vascular functionalities. [Lin Xinyi (2026); evidence level 4]
- Therefore, leucine represents the BCAA with the most compelling mechanistic and clinical evidence relevant to muscle-vascular interactions and healthy aging, justifying its emphasis in the present review. [Lin Xinyi (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For whey protein muscle randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Lin Che-Li (2026). Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta-Analysis and Meta-Regression of Randomized Controlled Trials. DOI: 10.3390/nu18091409. PMCID: PMC13165454. PMID: 42124009. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165454/
- Lin Xinyi (2026). Targeting muscle–vasculature crosstalk in aging through the integrative roles of L-citrulline, leucine, and exercise: focus on muscle metabolism, vascular function, and sarcopenia prevention. DOI: 10.3389/fnut.2025.1739173. PMCID: PMC13083166. PMID: 42005822. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13083166/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.